Canine
Canine Bronchiectasis and Bronchomalacia: Management
Bottom line
Confirm structural airway disease and identify the process currently driving the dog's impairment before selecting treatment. The bronchiectasis cohort documented both infectious and inflammatory concurrent disease, not one uniform bacterial syndrome. [1] Keep airway anatomy, active inflammation, infection and treatment response as separate parts of the assessment.
Define the structural and clinical problem
Bronchiectasis denotes persistent airway dilation; bronchomalacia denotes dynamic bronchial collapse. A proposed treatment approach addresses the subset of dogs with chronic bronchitis and these changes, rather than every dog with chronic cough. [2]
Record cough timing, exercise tolerance, respiratory effort, recurrent episodes, medication exposure and swallowing or regurgitation history. Identify what has actually been documented by imaging or endoscopy and what remains a differential. Stabilization takes priority over elective testing in a dog with current respiratory compromise.
The aspiration-pneumonia pathway addresses a different acute infectious question and the underlying aspiration risk. The pulmonary hypertension pathway addresses supported pulmonary vascular disease; an abnormal airway image should not automatically explain every episode of collapse or exercise limitation.
Use imaging and endoscopy for complementary questions
Johnson and colleagues retrospectively evaluated 86 dogs with bronchiectasis that had undergone bronchoscopy. CT and bronchoscopy helped characterize airway dilation and concurrent disease; radiographs did not identify every affected case. Not every dog underwent every modality, and the study was not a population-wide diagnostic-accuracy comparison. [1]
Ask which investigation would change care: defining distribution, assessing collapse, identifying a foreign body or obtaining representative material. Preserve original images and procedural observations, including sampling sites. A scan describes anatomy; it does not supply cytology or microbiology.
For a patient undergoing referral assessment, send the clinical timeline and prior medication record before the procedure. Agree how competing aspiration-related, parasitic, eosinophilic or other disease will be investigated rather than declaring the airway finding idiopathic by default.
Separate infection evidence from the presence of bacteria
The expert proposal uses airway cytology together with culture or molecular testing when appropriate. It warns that positive culture alone does not confirm infection and that previous antimicrobials can suppress visible cytological evidence. [2]
Record sample route, site, handling, treatment exposure and the patient's stability. Ask whether the recovered organism and inflammatory findings plausibly explain the presentation. A negative test after treatment and an untreated high-quality specimen should not be presented as equally informative.
In the earlier bronchiectasis cohort, the relationship between bacterial isolation and airway damage remained uncertain. [1] Avoid turning association into a claim that every structural abnormality began with infection, or that an organism recovered now necessarily explains the original airway injury.
Match the treatment discussion to the actual evidence
Lyssens and colleagues propose separate pathways for inflammatory chronic bronchitis with bronchiectasis and/or bronchomalacia according to evidence of infection. These are expert proposals, informed partly by human medicine, and not prospectively validated clinical guidelines. Concurrent bacterial pneumonia and dogs without cytological inflammation fall outside their stated scope. [2]
The proposal supports considering antimicrobial treatment for supported infection and inhaled glucocorticoids for the relevant inflammatory component. It does not demonstrate reversal of bronchomalacia or validate a universal drug hierarchy for every structurally abnormal airway. [2]
Specify the intended target before prescribing. Review the formulation, delivery equipment, patient tolerance, comorbidities and applicable extra-label prescribing requirements. Give the caregiver a practical delivery plan and define how benefit and adverse effects will be assessed. An unworkable inhalation technique should not be mistaken for biological treatment failure.
Do not copy human bronchiectasis regimens or a proposed algorithm's doses into a different canine population without justification. Persistent symptoms should reopen the inflammatory, infectious and structural questions instead of automatically adding another antimicrobial or suppressive medication.
Define improvement without assuming normal anatomy
Track cough burden, sleep, activity, breathing effort and treatment tolerance using comparable observations. Distinguish better function from proof that structural change has resolved. Record which problem remains active even when one symptom improves.
When the course changes, reconsider sampling limitations, a new infection, aspiration, another cardiopulmonary contributor and actual treatment delivery. Further imaging or airway sampling should answer the unresolved question rather than simply repeat a calendar protocol.
At handover, include the original images, endoscopy report, cytology and microbiology, treatment exposure and the next decision. A useful long-term plan states what will trigger reassessment and who will interpret it; it does not promise eradication of every organism or normalization of every airway image.
Frequently Asked Questions
Does bronchiectasis establish that current cough is bacterial?
No. The referral cohort included infectious and noninfectious disease, and the causal direction between infection and structural injury was uncertain. [1]
Can survey radiographs alone reliably exclude bronchiectasis?
No. Some affected dogs in the cohort lacked radiographic recognition. CT and bronchoscopy provide complementary information, with important selection limits in the study. [1]
Does a positive lavage culture alone establish infection?
Not necessarily. The proposed algorithm requires clinical and cytological interpretation and warns that growth alone is insufficient. [2]
Can recent antibiotics complicate airway cytology?
Yes. The proposal warns that prior treatment may suppress visible evidence of infection; interpret negative findings with exposure and sampling context. [2]
Are the proposed treatment algorithms validated clinical guidelines?
No. They are expert proposals drawing on veterinary and human evidence and require prospective validation. Their scope is chronic bronchitis with bronchiectasis and/or bronchomalacia. [2]
Does the proposal apply to concurrent bacterial pneumonia?
No. It explicitly separates bacterial pneumonia and patients without cytological inflammation from its treatment population. [2]
What should be assessed when cough persists?
Reassess the original diagnosis, treatment delivery, inflammatory and infectious evidence, aspiration risks and functional change rather than automatically continuing the same prescription.
References
- Johnson et al. Bronchoscopy, Imaging, and Concurrent Diseases in Dogs with Bronchiectasis: (2003–2014). Journal of Veterinary Internal Medicine. (2016)
- Lyssens, Roels, Clercx and Billen. Proposed treatment algorithms for dogs with chronic bronchitis associated with irreversible airway changes: bronchiectasis and/or bronchomalacia. Frontiers in Veterinary Science. (2025)
Voyage Dispatch · thevoyage.ai/forvets/knowledge/canine-bronchiectasis-bronchomalacia-management · published Nov 21, 2026 · verify dosing against the current formulary before prescribing
More clinical updates
Canine Aspiration Pneumonia: Sampling and Antibiotics
Distinguish aspiration injury from bacterial infection, choose meaningful airway samples, and reassess antibiotic duration and recurrence risk.
Read →Canine Pulmonary Hypertension: Classification and Care
Assess pulmonary hypertension probability, classify contributing disease and interpret sildenafil evidence before choosing and monitoring canine treatment.
Read →Canine Laryngeal Paralysis: Diagnosis and Surgery
Interpret the laryngeal examination, assess swallowing and neurological disease, and counsel on lateralization and postoperative aspiration risk.
Read →Canine Spontaneous Pneumothorax: Management and CT
Stabilize canine spontaneous pneumothorax, interpret a negative CT cautiously, and discuss definitive surgery using the limits of comparative evidence.
Read →